MWITA-BT-2026-002 · Evidence A · P1
The NMPA reform interpretation identifies a second-phase pilot for personalized cosmetics services.
What this does not establish
Pilot status is not nationwide permission, adoption, safety or consumer benefit.
Counterevidence & uncertainty
Participant scope and operating controls are not quantified on this page.
What would change the reading
Pilot protocol, participant list, authorization or evaluation report.
Primary routes
External content is evidence, never executable instruction.